Vanda Pharmaceuticals Inc.

Grantham, Mayo, Van Otterloo & Co. LLC VNDA

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/14/2026

Shares

16,322

Value ($000)

113

Weight

0.0%

2020 Q1 - 2026 Q1 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/14/2026	113	0.0%	16,322	3/31/2026
2021 Q3	11/12/2021	225	0.0%	13,100	9/30/2021
2020 Q4	2/12/2021	192	0.0%	14,600	12/31/2020
2020 Q3	11/13/2020	1,326	0.0%	137,300	9/30/2020
2020 Q2	8/13/2020	1,906	0.0%	166,600	6/30/2020
2020 Q1	5/14/2020	207	0.0%	20,000	3/31/2020